Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer
Choose from the criteria below to find an activity that fits you best.
|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
Irritable Bowel Disease (IBD) encompasses a group of gastrointestinal chronic conditions including Ulcerative Colitis and Crohn’s Disease. This group of diseases can have a very negative and severe effect on a patient’s quality of life. IBD can lead to severe physical complications requiring surgery and/or hospitalization. When selecting drug therapies for patients with IBD, there are multiple things to consider. This activity discusses both Ulcerative Colitis and Crohn’s, the stepwise approach to treatment considerations, and financial assistance options to provide the technician with a better understanding of these disease processes and the therapies used to treat them.
The target audience for this activity includes pharmacy technicians. Upon completion of this activity, participants will be able to:
Lopa Joshi, PharmD
Henry Ford Pharmacy Advantage Specialty Pharmacy
It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Lopa Joshi has received consulting fees and fees for non-CME/CE services from AbbVie.
Release Date: October 29, 2021
Expiration Date: October 29, 2024
This CE activity is jointly provided by ProCE, LLC and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-232-H01-T has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.